[Final bedside verification: results of a national survey of reagents and devices used in France].
The national reference Center for blood groups checked samples of reagents and devices used in France for a definitive verification of pretransfusion ABO tests performed at the patient's bedside, as defined by French health authority regulations. The results of an initial inquiry was published in 1991. The new study shows no significant improvement of the quality of reagents and devices. This is a major concern considering the importance of ABO incompatibility in severe hemolytic transfusion reactions.
Noizat-Pirenne
F
F
Centre national de référence pour les groupes sanguins, Inserm U76, Paris, France.
Le Pennec
P Y
PY
Lascaux
J M
JM
Fraval
D
D
Zaoui
F
F
Rouger
P
P
D000017:ABO Blood-Group System / Q000032:analysis*; D001771:Blood Banks / Q000706:statistics & numerical data*; D001787:Blood Group Incompatibility / Q000175:diagnosis*; D001788:Blood Grouping and Crossmatching / Q000295:instrumentation / Q000379:methods / Q000706:statistics & numerical data*; D001803:Blood Transfusion; D003625:Data Collection; D017707:Erythrocyte Transfusion; D005069:Evaluation Studies as Topic; D005568:Forms and Records Control; D005602:France; D006801:Humans; D007202:Indicators and Reagents; D008499:Medical Records; D015203:Reproducibility of Results; D012449:Safety; D000094902:Blood Banking / Q000379:methods
D000017:ABO Blood-Group System; D007202:Indicators and Reagents